Future Oncology
Volume 18, 2022 - Issue 1
Open access
4,627
Views
0
CrossRef citations to date
0
Altmetric
Review
The role of Globo H and SSEA-4 in the Development and Progression of Cancer, and their Potential as Therapeutic Targets
Darren S Sigal1 Director, GI Oncology, Scripps Clinic & Scripps MD Anderson Cancer Center, 10710 N Torrey Pines Road, La Jolla, CA92037,USACorrespondence[email protected]
https://orcid.org/0000-0001-7839-1230View further author information
David J Hermel2 Scripps Clinic & Scripps MD Anderson Cancer Center, 10710 N Torrey Pines Road, LA Jolla, CA92037, USA
https://orcid.org/0000-0001-6342-6023View further author information
Pei Hsu3 Medical Advisor, Medical Affairs & Clinical Development, OBI Pharma Inc. 7F, No. 369, Zhongxiao E Road, Nangang District, Taipei City, 115, TaiwanView further author information
& Tillman Pearce4 Chief Medical Officer, OBI Pharma USA Inc., 6020 Cornerstone Court W, Suite 200, San Diego, CA92121, USAView further author information
Pages 117-134
|
Received 02 Sep 2021, Accepted 07 Oct 2021, Published online: 04 Nov 2021
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.